Page last updated: 2024-12-08

methylglucamine ioglycamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methylglucamine ioglycamide: RN given refers to meglumine salt[2:1] [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159736
MeSH IDM0052315

Synonyms (21)

Synonym
glucitol, 1-deoxy-1-(methylamino)-, 3,3'-(oxybis(methylenecarbonylimino))bis(2,4,6-triiodobenzoate) (2:1) (salt), d-
meglumine ioglycamide
ioglycamic acid n-methylglucamine
bilivison
ioglycamate meglumine
methylglucamine ioglycamide
d-glucitol, 1-deoxy-1-(methylamino)-, 3,3'-(oxybis(1-oxo-2,1-ethanediyl)imino))bis(2,4,6-triiodobenzoate) (2:1) (salt)
bilivistan
biligram
14317-18-1
l9d9y4yulv ,
unii-l9d9y4yulv
ioglycamic acid meglumine salt [mi]
ioglycamate meglumine [who-dd]
ioglycamic acid meglumine salt
29897-96-9
d-glucitol, 1-deoxy-1-(methylamino)-, 3,3'-(oxybis((1-oxo-2,1-ethanediyl)imino))bis(2,4,6-triiodobenzoate) (2:1)
1-deoxy-1-(methylamino)-d-glucitol, 3,3'-[oxybis[(1-oxo-2,1-ethanediyl)imino]]bis[2,4,6-triiodobenzoate] (2:1)
DTXSID60162330
Q27282870
3-[[2-[2-(3-carboxy-2,4,6-triiodoanilino)-2-oxoethoxy]acetyl]amino]-2,4,6-triiodobenzoic acid;(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (83.33)18.7374
1990's2 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.52 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.14%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]